TXNDC12 and neoplasm: Compared to the control group, the knockdown of TXNDC12 resulted in a 3-fold increase in IKE-induced tumor suppression, which was further inhibited by the ferroptosis inhibitor liproxstatin-1 (Figures 6D and 6E).